Dr. Kuan-lin Huang and his team at Mount Sinai Hospital won the $1 million Alzheimer’s Insights AI Prize for developing Biomni-AD, an advanced AI platform that accelerates scientific insights from complex biomedical data. This innovation is crucial as it helps researchers quickly identify potential drug targets and biomarkers, potentially speeding up the development of new treatments for Alzheimer's disease.
Read the full article at Digital Journal
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.

![[AINews] The Unreasonable Effectiveness of Closing the Loop](/_next/image?url=https%3A%2F%2Fmedia.nemati.ai%2Fmedia%2Fblog%2Fimages%2Farticles%2F600e22851bc7453b.webp&w=3840&q=75)



